Leprosy
ナビゲーションに移動
検索に移動
Navigation Menu |
General issues of Vaccine | |||||||
---|---|---|---|---|---|---|---|
|
General issues of Travel med. | ||||||||
---|---|---|---|---|---|---|---|---|
|
Immunology | |||||||
---|---|---|---|---|---|---|---|
|
Epi & Stats | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Virus | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
COVID-19 | |||||
---|---|---|---|---|---|
|
Bacteria | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Rickettsia | |||||
---|---|---|---|---|---|
|
Protozoa | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Fungi | |||||||
---|---|---|---|---|---|---|---|
|
Nematode (roundworm) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Trematode (fluke, distoma) | |||||||
---|---|---|---|---|---|---|---|
|
Cestode (tapeworm) | ||||||
---|---|---|---|---|---|---|
|
Medical Zoology | ||||||||
---|---|---|---|---|---|---|---|---|
|
clinical picture
- manifests in skin and peripheral nerves
- papule, macule, plaque, hypopigmentation, nodule
- loss of sensation, paralysis, amyotrophy
- incubation months to >30 years
Ridley-Jopling classification
- TT - tuberculoid
- BT - borderline tuberculoid
- BB - borderline borderline
- BL - borderline lepromatous
- LL - lepromatous
- TT direction - abnormal or significant immune response (granulomatous) against few M. leprae bacilli
- PB in WHO classification
- infiltrated plaque
- well-defined, sharp border
- single skin lesion
- localized, asymmetrical
- loss of sensation at skin lesion
- in histopathology nerves are surrounded by granuloma
- LL direction - least cellular immunity or allergic reaction against much amount of M. leprae bacilli
- MB in WHO classification
- macule, papule, nodule
- multiple skin lesion
- widespread, symmetrical
- loss of sensation at ...
- in histopathology diffuse infiltrate of foamy histiocytes (macrophages) in dermis
- Leonine facies: madarosis, saddle nose
diagnosis
- WHO criteria: one or more cardinal signs
- skin lesion consistent with leprosy with definite sensory loss
- thickened nerve, peripheral neuropathy
- skin smear...
treatment
- MB >5 lesions
- PB 1-5 lesions
leprosy reaction
- can develop at anytime on clinical course
- either before or after commencement of treatment
- even after completion of treatment
- incidence 20-60% in multiple studies
- Type 1 reversal reaction
- cell-mediated delayed hypersensitivity
- reddish, swollen, warm, painful, tender
- systemic condition fair
- Type 2 erythema nodosum leprosum (ENL)
- antigen-antibody immune complex reaction
- multiple, distributed bilaterally and symmetrically
- with high grade fever and malaise
treatment of leprosy reaction
- antipyretics, NSAIDs
- steroid
- immunosuppressant